Pyrimethamine sensitizes pituitary adenomas cells to temozolomide through cathepsin B-dependent and caspase-dependent apoptotic pathways

被引:31
作者
Dai, Congxin [1 ,2 ]
Zhang, Bo [3 ]
Liu, Xiaohai [1 ,2 ]
Guo, Kai [3 ]
Ma, Sihai [1 ,2 ]
Cai, Feng [1 ,2 ]
Yang, Yakun [1 ,2 ]
Yao, Yong [1 ,2 ]
Feng, Ming [1 ,2 ]
Bao, Xinjie [1 ,2 ]
Deng, Kan [1 ,2 ]
Jiao, Yonghui [1 ,2 ]
Wei, Zhenqing [1 ,2 ]
Wei Junji [1 ,2 ]
Xing, Bing [1 ,2 ]
Lian, Wei [1 ,2 ]
Wang, Renzhi [1 ,2 ]
机构
[1] Chinese Acad Med Sci, Peking Union Med Coll Hosp, Dept Neurosurg, Beijing 100730, Peoples R China
[2] Peking Union Med Coll, Beijing 100730, Peoples R China
[3] Dalian Med Univ, Affiliated Hosp 1, Dept Neurosurg, Dalian, Liaoning, Peoples R China
基金
中国国家自然科学基金;
关键词
invasive pituitary adenomas; refractory; temozolomide; pyrimethamine; folate metabolism; MELANOMA-CELLS; INDUCED CYTOTOXICITY; STRAND BREAKS; PARP CLEAVAGE; CYTOCHROME-C; THERAPY; TUMORS; RELEASE; MATRIX-METALLOPROTEINASE-9; SULFADOXINE/PYRIMETHAMINE;
D O I
10.1002/ijc.28199
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Invasive pituitary adenomas (PAs) are generally refractory to conventional therapy and salvage treatment with temozolomide (TMZ). In addition to antiprotozoan effects, pyrimethamine (PYR) has recently shown its strong antitumor activity as an antineoplastic agent or in combination with TMZ in metastatic melanoma cells. In this study, the effects of TMZ, PYR or TMZ/PYR combination on rat/mouse PA cell lines T3-1, GH3, MMQ and ATt-20 as well as GH3 xenograft tumor model were evaluated. TMZ/PYR combination synergistically inhibited proliferation, invasion and induced apoptosis of these PA cell lines in vitro. Strikingly, combination treatment with TMZ and PYR produced synergistic antitumor activity and enhanced the survival rate of GH3 xenograft tumor models without increasing systemic side effects. In addition, TMZ/PYR induced cell cycle arrest, increased DNA damage, upregulated the expression of cathepsin B, BAX, cleaved PARP and phosphorylated histone H2AX as well as elevated caspase3/7, 8 and 9 activities. The decreased expression of Bcl-2, MMP-2 and MMP-9 alone with cytochrome c release from mitochondria into the cytosol was also observed in the TMZ/PYR combination group. The increase in cell apoptosis due to combination with PYR was rescued by leucovorin. These data suggest that PYR may enhance the efficacy of TMZ via triggering both cathepsin B-dependent and caspase-dependent apoptotic pathways. Therefore, combination of PYR and TMZ may provide a novel regimen for invasive PAs refractory to standard therapy and TMZ. What's new? Pituitary tumors are usually benign, slow-growing adenomas, but roughly a third grow rapidly with aggressive invasion of adjacent structures. In this study, the authors present evidence that the antimalarial agent pyrimethamine, known to inhibit tetrahydrofolic acid synthesis, represents a potential new therapy option for patients with invasive pituitary adenomas refractory to conventional treatment regimens. The authors show that pyrimethamine enhances the ability of the chemotherapeutic drug temozolomide to inhibit cell proliferation, induce apoptosis, and prevent invasion, possibly through cathepsin B- and caspase-dependent apoptosis induced by inhibition of the folate metabolism. Thus, the combination of pyrimethamine and temozolomide may be a new alternative in invasive pituitary adenoma therapy.
引用
收藏
页码:1982 / 1993
页数:12
相关论文
共 42 条
  • [11] Sulfadoxine/pyrimethamine alone or with amodiaquine or artesunate for treatment of uncomplicated malaria: a longitudinal randomised trial
    Dorsey, G
    Njama, D
    Kamya, MR
    Cattamanchi, A
    Kyabayinze, D
    Staedke, SG
    Gasasira, A
    Rosenthal, PJ
    [J]. LANCET, 2002, 360 (9350) : 2031 - 2038
  • [12] Pyrimethamine induces apoptosis of melanoma cells via a caspase and cathepsin double-edged mechanism
    Giammarioli, Anna Maria
    Maselli, Angela
    Casagrande, Andrea
    Gambardella, Lucrezia
    Gallina, Angelo
    Spada, Massimo
    Giovannetti, Antonello
    Proietti, Enrico
    Malorni, Walter
    Pierdominici, Marina
    [J]. CANCER RESEARCH, 2008, 68 (13) : 5291 - 5300
  • [13] Differential effects of the glycolysis inhibitor 2-deoxy-D-glucose on the activity of pro-apoptotic agents in metastatic melanoma cells, and induction of a cytoprotective autophagic response
    Giammarioli, Anna Maria
    Gambardella, Lucrezia
    Barbati, Cristiana
    Pietraforte, Donatella
    Tinari, Antonella
    Alberton, Manuela
    Gnessi, Lucio
    Griffin, Roger J.
    Minetti, Maurizio
    Malorni, Walter
    [J]. INTERNATIONAL JOURNAL OF CANCER, 2012, 131 (04) : E337 - E347
  • [14] Matrix metalloproteinase-9, a potential biological marker in invasive pituitary adenomas
    Gong, Jian
    Zhao, Yunge
    Abdel-Fattah, Rana
    Amos, Samson
    Xiao, Aizhen
    Lopes, M. Beatriz S.
    Hussaini, Isa M.
    Laws, Edward R.
    [J]. PITUITARY, 2008, 11 (01) : 37 - 48
  • [15] Humanin peptide suppresses apoptosis by interfering with Bax activation
    Guo, B
    Zhai, DY
    Cabezas, E
    Welsh, K
    Nouraini, S
    Satterthwait, AC
    Reed, JC
    [J]. NATURE, 2003, 423 (6938) : 456 - 461
  • [16] A randomized phase I and pharmacological trial of sequences of 1,3-bis(2-chloroethyl)-1-nitrosourea and temozolomide in patients with advanced solid neoplasms
    Hammond, LA
    Eckardt, JR
    Kuhn, JG
    Gerson, SL
    Johnson, T
    Smith, L
    Drengler, RL
    Campbell, E
    Weiss, GR
    Von Hoff, DD
    Rowinsky, EK
    [J]. CLINICAL CANCER RESEARCH, 2004, 10 (05) : 1645 - 1656
  • [17] Cerebral symptomatic toxoplasmosis treated by sulfadoxine/pyrimethamine treatment. About 6 patients
    Iba-Ba, Josaphat
    Ibouili, Rufin Bignoumba
    Kombila, Jean-Baptiste Moussavou
    Nzenze, Jean Raymond
    Drave, Madani
    Essola, Laurence
    Ivala, Mathieu
    Mistoul, Irene
    Kerault, Lydie
    Menye, Blaise
    Boguikouma, Jean-Baptiste
    [J]. THERAPIE, 2008, 63 (01): : 71 - 72
  • [18] CHARACTERIZATION OF THE MMQ CELL, A PROLACTIN-SECRETING CLONAL CELL-LINE THAT IS RESPONSIVE TO DOPAMINE
    JUDD, AM
    LOGIN, IS
    KOVACS, K
    ROSS, PC
    SPANGELO, BL
    JARVIS, WD
    MACLEOD, RM
    [J]. ENDOCRINOLOGY, 1988, 123 (05) : 2341 - 2350
  • [19] Role of autophagy in temozolomide-induced cytotoxicity for malignant glioma cells
    Kanzawa, T
    Germano, IM
    Komata, T
    Ito, H
    Kondo, Y
    Kondo, S
    [J]. CELL DEATH AND DIFFERENTIATION, 2004, 11 (04) : 448 - 457
  • [20] Khorramizadeh Mohammad Reza, 2007, Iran Biomed J, V11, P223